Home » Stocks » RVPH

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Stock Price: $8.88 USD -0.02 (-0.22%)
Updated Jan 26, 2021 4:00 PM EST - Market closed
After-hours: $8.70 -0.18 (-2.03%) Jan 26, 4:12 PM
Market Cap 81.70M
Revenue (ttm) n/a
Net Income (ttm) -1.15M
Shares Out 2.81M
EPS (ttm) -0.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 26
Last Price $8.88
Previous Close $8.90
Change ($) -0.02
Change (%) -0.22%
Day's Open 8.90
Day's Range 8.72 - 8.91
Day's Volume 3,093
52-Week Range 7.92 - 11.88

News

Hide News
GlobeNewsWire - 1 month ago

Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHW

PRNewsWire - 4 months ago

NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Tenzing Acquisition Corp.

Newsfile Corp - 6 months ago

New York, New York--(Newsfile Corp. - July 24, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who own Tenzing Acquisition Corp.

About RVPH

Reviva Pharmaceuticals Holdings, a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.

Industry
Biotechnology
Founded
2006
CEO
Dr. Laxminarayan Bhat
Employees
5
Stock Exchange
NASDAQ
Ticker Symbol
RVPH
Full Company Profile

Financial Performance

Financial Statements